Tuesday, September 1, 2026 · Five AI analysts screened this index for stocks with the best shot at gaining +5% within 30 days
Neutral Normal choppiness · VIX 16.1
The FTSE 100 is seeing a sharp rotation into miners and select financials/business-services names, with metals and gold producers rallying hard on strong one-day and 30-day gains, while pharma, tobacco, luxury and some banks are dragging the index lower. Momentum is concentrated rather than broad-based, so selectivity matters more than index-level direction.
Which of today's picks to actually take, and at what size, given what you are already holding. Each pick's own Suggested Allocation sizes it in isolation; this table applies the portfolio limits — at most 20 open positions and 60% of the portfolio committed in total. Run with --capital 25000 to see these sizes as order amounts rather than percentages.
| Rank | Stock | Action | Size | Entry → Target | Notes |
|---|---|---|---|---|---|
| #1 | LSEG.L | SKIP | — | £8,836.00 → £9,277.80 stop £7,996.58 |
Position cap reached — 111 of 20 slots in use. |
| #2 | HSX.L | SKIP | — | £1,868.00 → £1,961.40 stop £1,780.20 |
Position cap reached — 111 of 20 slots in use. |
| #3 | CRDA.L | SKIP | — | £3,360.00 → £3,528.00 stop £3,118.08 |
Position cap reached — 111 of 20 slots in use. |
| #4 | RKT.L | SKIP | — | £5,360.00 → £5,628.00 stop £5,011.60 |
Position cap reached — 111 of 20 slots in use. |
Already open: AMP (to Sep 3), RJF (to Sep 4), NVDA (to Sep 5), SWK (to Sep 6), FAST (to Sep 9), WAT (to Sep 9), LLY (to Sep 10), DRI (to Sep 11), DXCM (to Sep 11), BDX (to Sep 12), BLK (to Sep 12), EXPD (to Sep 13) … and 99 more. Symbols you already hold were excluded from this run's candidates rather than re-picked.
Position-sizing guidance only — half-Kelly per pick, bounded by the limits above. Not personal investment advice.
London Stock Exchange Group runs stock exchanges and sells financial data and analytics to banks and investors worldwide. The shares are pushing higher with a bullish momentum signal and a tightening trading range that often precedes a breakout, and the stock is beating the wider market. The key risk is that it's still trading a touch below its long-term average price, so the bigger multi-month trend isn't fully confirmed yet.
Why the AI likes it
What could go wrong
Calibrated probability: 68% (raw model estimate: 64%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Hiscox is a specialty insurer that covers businesses and individuals against risks like property damage and cyber incidents. Its shares are climbing steadily, trading above both their short- and long-term averages, and are clearly outpacing the broader market, which points to real investor demand rather than a one-day blip. The main risk is that insurers can get hit hard by unexpected large claims, and a broader market wobble could stall the run.
Why the AI likes it
What could go wrong
Calibrated probability: 68% (raw model estimate: 67%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Croda International makes specialty chemical ingredients used in skincare, health products, and industrial applications. The shares are in a steady uptrend, sitting above both their short- and long-term averages while beating the broader market, with a healthy (not overheated) momentum reading. The main risk is that trading-volume patterns look a bit weaker than the price gains would suggest, hinting the rally could lack full conviction.
Why the AI likes it
What could go wrong
Calibrated probability: 68% (raw model estimate: 63%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Reckitt Benckiser owns well-known household and health brands like Dettol and Nurofen. The shares have healthy momentum, a bullish technical signal, and are beating the broader market over the past month. The key risk is that the stock is still trading below its longer-term average price, meaning it's recovering from a prior decline rather than sitting in a firmly established uptrend.
Why the AI likes it
What could go wrong
Calibrated probability: 68% (raw model estimate: 61%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
This report identifies stocks with an AI-assessed probability of gaining +5% within 30 calendar days (target exit by October 1, 2026). Picks are ranked by how many independent AI agents agreed — more agreement means higher conviction. The guide below tells you exactly how to act on them.
Step-by-Step Action Plan
Position Sizing by Conviction Tier
Size each position according to the coloured border on its pick card. Cap your total exposure across all picks from this report at 25% of your overall trading budget.
| Agents Agreeing | What It Means | Max Allocation Per Pick |
|---|---|---|
| 5/5 | Highest conviction — all five independent analytical checks passed | Up to 10% |
| 4/5 | Very high conviction — four of five independent checks aligned | Up to 8% |
| 3/5 | High conviction — three agents independently agreed | Up to 6% |
| 2/5 | Moderate conviction — two agents independently agreed | Up to 4% |
| 1 Agent | Speculative — solo pick, admitted only at Very High confidence | Up to 2% |
The Three Exit Rules
A plain-English guide to every figure shown on each pick card — what it means, how it is calculated, and what a good or bad value looks like.
Scout scanned 100 FTSE 100 constituents and short-listed 25 candidates for deep analysis by the five analysts. Here is what happened to each one.
Checks 30-day price history for every candidate before making any selection. Requires positive period return and positive 5-day momentum as mandatory gates. Ranks picks by proximity to their period high and adjusts probability based on volume. Uses news only to rule out major negative catalysts.
Searches earnings results, analyst upgrades, and revenue trends before checking price data. Requires at least one verifiable fundamental catalyst — earnings beat, analyst upgrade, or revenue acceleration — within the last 60 days. Favours stocks with strong fundamentals trading below recent highs (value entry).
Hunts for specific events within the last 21 days: FDA approvals, major contract wins, product launches, earnings surprises, or significant analyst upgrades. Requires a positive price reaction confirming the market is recognising the catalyst. Also scans for upcoming events that could drive further gains.
Maps the macroeconomic regime (risk-on / risk-off / neutral) and identifies sectors benefiting from current conditions before looking at individual stocks. Only selects stocks from macro-aligned sectors with confirmed sector tailwinds. Adjusts for interest rate sensitivity and geopolitical factors.
Reviews the final picks after all four analysts agree and actively challenges each bull thesis. Searches for bearish technical signals, negative news, insider selling, and elevated short interest that the agreeing agents may have underweighted. Produces evidence-based counter-arguments shown on each pick card.
Pure-quant analyst: no news, no narrative, only numbers. Identifies mean-reversion setups from RSI extremes (<35) with momentum turning, Bollinger squeeze breakouts, and multi-factor quant scores using RSI, MACD, OBV, short interest, and insider transaction data. Counterbalances narrative bias across the four analyst agents.